These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Subcutaneous urinary diversions for palliative treatment of pelvic malignancies. Desgrandchamps F; Cussenot O; Meria P; Cortesse A; Teillac P; Le Duc A J Urol; 1995 Aug; 154(2 Pt 1):367-70. PubMed ID: 7541851 [TBL] [Abstract][Full Text] [Related]
5. Pyelovesical bypass graft for palliative management of malignant ureteric obstruction: optimizing the technique by percutaneous access to the bladder using a split Amplatz sheath. Aminsharifi A; Taddayun A; Jafari M; Ghanbarifard E Urology; 2010 Oct; 76(4):993-5. PubMed ID: 20110107 [TBL] [Abstract][Full Text] [Related]
6. [Prosthetic pyelovesical and pyelocutanous bypass. A palliative therapy concept in tumor-induced chronic hydronephprosis]. Loertzer H; Jurczok A; Wagner S; Fornara P Urologe A; 2003 Aug; 42(8):1053-9. PubMed ID: 14513229 [TBL] [Abstract][Full Text] [Related]
7. Palliative Subcutaneous Tunneled Nephrostomy Tube (PSTN): a simple and effective technique for management of malignant extrinsic ureteral obstruction. Bell DG; Fischer MA Can J Urol; 2002 Feb; 9(1):1470-4. PubMed ID: 11886602 [TBL] [Abstract][Full Text] [Related]
8. Total ureteral replacement by subcutaneous pyelovesical bypass in ureteral necrosis after renal transplantation. Desgrandchamps F; Duboust A; Teillac P; Idatte JM; Le Duc A Transpl Int; 1998; 11 Suppl 1():S150-1. PubMed ID: 9664967 [TBL] [Abstract][Full Text] [Related]
9. Subcutaneous pyelovesical bypass - Detour bypass - as a solution for ureteric obstruction. Wrona AJ; Zgajewski J; Kopeć N; Chodor D; Kopcza P; Klekot S Cent European J Urol; 2017; 70(4):429-433. PubMed ID: 29410898 [TBL] [Abstract][Full Text] [Related]
10. Morbidity and long-term results of subcutaneous pyelovesical bypass in chronic ureteral obstruction. Nouaille A; Descazeaud A; Desgrandchamps F; Bazin D; Daudon M; Masson Lecomte A; Mongiat-Artus P; Meria P Prog Urol; 2021 May; 31(6):348-356. PubMed ID: 33455824 [TBL] [Abstract][Full Text] [Related]
11. Percutaneous nephrostomy versus ureteral stents for diversion of hydronephrosis caused by stones: a prospective, randomized clinical trial. Mokhmalji H; Braun PM; Martinez Portillo FJ; Siegsmund M; Alken P; Köhrmann KU J Urol; 2001 Apr; 165(4):1088-92. PubMed ID: 11257644 [TBL] [Abstract][Full Text] [Related]
12. [Clinical application of subcutaneous nephrovesical bypass system]. Li J; Wang XF Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 42(4):473-5. PubMed ID: 20721268 [TBL] [Abstract][Full Text] [Related]
13. Intractable hemorrhagic cystitis after hematopoietic stem cell tranplantation--is there a role for early urinary diversion in children? Lukasewycz SJ; Smith AR; Rambachan A; MacMillan ML; Lewis JM; Shukla AR J Urol; 2012 Jul; 188(1):242-6. PubMed ID: 22595064 [TBL] [Abstract][Full Text] [Related]
14. Ureteric stents vs percutaneous nephrostomy for initial urinary drainage in children with obstructive anuria and acute renal failure due to ureteric calculi: a prospective, randomised study. ElSheemy MS; Shouman AM; Shoukry AI; ElShenoufy A; Aboulela W; Daw K; Hussein AA; Morsi HA; Badawy H BJU Int; 2015 Mar; 115(3):473-9. PubMed ID: 24698195 [TBL] [Abstract][Full Text] [Related]
15. Impact of palliative urinary diversion by percutaneous nephrostomy drainage and ureteral stenting among patients with advanced cervical cancer and obstructive uropathy: a prospective cohort. Lapitan MC; Buckley BS J Obstet Gynaecol Res; 2011 Aug; 37(8):1061-70. PubMed ID: 21481096 [TBL] [Abstract][Full Text] [Related]
16. Maintaining quality of life after palliative diversion for malignant ureteral obstruction. Markowitz DM; Wong KT; Laffey KJ; Bixon R; Nagler HM; Martin EC Urol Radiol; 1989; 11(3):129-32. PubMed ID: 2480679 [TBL] [Abstract][Full Text] [Related]